EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Challenges and Opportunities in Interdisciplinary Research and Real-World Data for Treatment Sequences in Health Technology Assessments

Jen-Yu Amy Chang iD, James B Chilcott iD, Nicholas R Latimer iD

PharmacoEconomics · 2024-05 · 42 (5) · 487-506

DOI: 10.1007/s40273-024-01363-1 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift PharmacoEconomics, online erschienen am 01.04.2024. Verfasst von Jen-Yu Amy Chang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Sheffield Centre for Health and Related Research (SCHARR), Division of Population Health, School of Medicine and Population Health, University of She…. Hauptthemen laut MEDLINE: Interdisciplinary Research, Technology Assessment, Biomedical. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 123 Literaturangaben. Gefördert von: Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With an ever-increasing number of treatment options, the assessment of treatment sequences has become crucial in health technology assessment (HTA). This review systematically explores the multifaceted challenges inherent in evaluating sequences, delving into their interplay and nuances that go beyond economic model structures. We synthesised a 'roadmap' of literature from key methodological studies, highlighting the evolution of recent advances and emerging research themes. These insights were compared against HTA guidelines to identify potential avenues for future research. Our findings reveal a spectrum of challenges in sequence evaluation, encompassing selecting appropriate decision-analytic modelling approaches and comparators, deriving appropriate clinical effectiveness evidence in the face of data scarcity, scrutinising effectiveness assumptions and statistical adjustments, considering treatment displacement, and optimising model computations. Integrating methodologies from diverse disciplines-statistics, epidemiology, causal inference, operational research and computer science-has demonstrated promise in addressing these challenges. An updated review of application studies is warranted to provide detailed insights into the extent and manner in which these methodologies have been implemented. Data scarcity on the effectiveness of treatment sequences emerged as a dominant concern, especially because treatment sequences are rarely compared in clinical trials. Real-world data (RWD) provide an alternative means for capturing evidence on effectiveness and future research should prioritise harnessing causal inference methods, particularly Target Trial Emulation, to evaluate treatment sequence effectiveness using RWD. This approach is also adaptable for analysing trials harbouring sequencing information and adjusting indirect comparisons when collating evidence from heterogeneous sources. Such investigative efforts could lend support to reviews of HTA recommendations and contribute to synthesising external control arms involving treatment sequences.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interdisciplinary ResearchTechnology Assessment, BiomedicalHumansDecision Support TechniquesModels, EconomicResearch DesignSystematic Reviews as TopicClinical Trials as Topic

Autor:innen und Institutionen

  • Sheffield Centre for Health and Related Research (SCHARR), Division of Population Health, School of Medicine and Population Health, University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, UK. jy.a.ch…
  • Sheffield Centre for Health and Related Research (SCHARR), Division of Population Health, School of Medicine and Population Health, University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, UK.
  • Delta Hat Limited, Nottingham, UK.

ORCID-Profile: Jen-Yu Amy Chang, James B Chilcott, Nicholas R Latimer

Förderung

  • Wellcome Trust

Zitieren

APA

Chang, J. A., Chilcott, J. B., & Latimer, N. R. (2024). Challenges and Opportunities in Interdisciplinary Research and Real-World Data for Treatment Sequences in Health Technology Assessments. PharmacoEconomics, 42(5), 487-506. https://doi.org/10.1007/s40273-024-01363-1

Vancouver

Chang JA, Chilcott JB, Latimer NR. Challenges and Opportunities in Interdisciplinary Research and Real-World Data for Treatment Sequences in Health Technology Assessments. PharmacoEconomics. 2024;42(5):487-506. doi:10.1007/s40273-024-01363-1

BibTeX
@article{Chang2024,
  author = {Chang, Jen-Yu Amy and Chilcott, James B and Latimer, Nicholas R},
  title = {Challenges and Opportunities in Interdisciplinary Research and Real-World Data for Treatment Sequences in Health Technology Assessments},
  journal = {PharmacoEconomics},
  year = {2024},
  volume = {42},
  number = {5},
  pages = {487--506},
  doi = {10.1007/s40273-024-01363-1}
}
Kostenlos starten →